Indegene: Life Sciences Leaders Discuss AI at Digital Summit 2026

Indegene Limited hosted its eighth annual Digital Summit 2026, convening over 200 life sciences leaders to discuss operationalizing AI for enterprise outcomes. The event highlighted advancements in AI applications, customer engagement, and future of work strategies. It also featured the VITAL Awards, recognizing leaders for their impact on organizational and market advancements in the life sciences sector.

Indegene Digital Summit 2026 Explores AI in Life Sciences

The eighth edition of the Indegene Digital Summit 2026 brought together more than 200 senior leaders from the global life sciences industry in Philadelphia on September 22, 2026. The summit’s central theme, “From Promise to Performance: Operationalizing AI for Enterprise Outcomes,” focused on the challenges and opportunities in translating AI investments into tangible business results. Discussions covered crucial areas such as customer engagement, the future of work, Al-enabled business models, and the integration of AI into operational strategies.

Key Discussions and Themes

Attendees engaged in peer-led discussions on critical industry topics, including the necessity of adapting operating models for the AI era, the transformation of work, data management, decision-making processes, and strategic partnerships. The summit also touched upon evolving U.S. drug approval policies, point-of-care AI, and the role of digital leadership in shaping AI strategies. The exchange of insights aimed to drive action and foster innovation within the life sciences sector.

VITAL Awards Honor Industry Leaders

During the summit, the second annual VITAL Awards were presented, celebrating leaders who have made significant contributions to the life sciences industry. Awards were presented in two categories: Organizational Impact and Market Impact, with special recognition for Transformational Leadership. The honorees were recognized for driving meaningful change, innovation, and measurable impact in their respective organizations and the broader industry. Manish Gupta, Chairman and CEO of Indegene, congratulated the awardees, emphasizing their role in transforming ideas into measurable impact.

Indegene’s Role in Life Sciences

Indegene Limited, a strategic operating partner for the life sciences industry, orchestrates commercial, medical, R&D, and safety operations. Trusted by top biopharma companies, Indegene leverages its life sciences expertise with AI-embedded platforms and governed operating models to enhance speed, consistency, and compliance in critical operations. The company’s focus is on integrating technology to drive measurable outcomes in regulated environments.

Source: BSE

Previous Article

NCL Research: GCM Capital Advisors Acquires 5.54% Stake

Next Article

REC Limited: Sells Two Subsidiaries for Project SPVs